DreamCIS Inc (223250.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Services · South Korea · ISIN KR7223250002
DreamCIS Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 58.65 bn KRW | 66.63 bn KRW |
| Gross profit | 17.86 bn KRW | 19.38 bn KRW |
| Operating income | 5.06 bn KRW | 5.24 bn KRW |
| EBIT | 6.38 bn KRW | 11.21 bn KRW |
| Net income | 5.28 bn KRW | 7.13 bn KRW |
| Diluted EPS – continuing operations | 221.86 KRW | – |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada. It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.
More stocks
- TECOGEN INC. (TGEN)
- Evertex Fabrinology Ltd (1470.TW)
- Lumir Inc. (474170.KQ)
- Midnight Sun Mining Corp (MMA.V)
- Apex Science & Engineering Corp (3052.TW)
- Heidmar Maritime Holdings Corp. Common Stock (HMR)
- Hyundai E P (089470.KS)
- Taiwan Bio Therapeutics Co., Ltd (6892.TWO)
- Daelim Paper Co.Ltd (017650.KQ)
- Halla Eng&Cons (014790.KS)
- Woosu AMS Co.Ltd (066590.KQ)
- P.A. Resources Bhd (7225.KL)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.